Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Escalon Medical's ebitda for the twelve months ending Jun 30, 2026 was $67.82K, down 60.3% year over year. For fiscal 2026 it was $67.82K, down 60.3% from the year before. The highest annual figure on record is $523.75K in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $67.82K | -60.3% |
| FY2025 | Jun 30, 2025 | $171.04K | – |
| FY2024 | Jun 30, 2024 | -$58.46K | -111.2% |
| FY2023 | Jun 30, 2023 | $523.75K | – |
| FY2022 | Jun 30, 2022 | -$421.63K | -3893.4% |
| FY2021 | Jun 30, 2021 | $11.12K | – |
| FY2020 | Jun 30, 2020 | -$1.35M | – |
| FY2019 | Jun 30, 2019 | -$202.82K | -179.9% |
| FY2018 | Jun 30, 2018 | $253.94K | – |
| FY2017 | Jun 30, 2017 | -$580.98K | – |
| FY2016 | Jun 30, 2016 | -$1.12M | – |
| FY2015 | Jun 30, 2015 | -$1.04M | – |
| FY2014 | Jun 30, 2014 | -$344.92K | – |
| FY2013 | Jun 30, 2013 | -$1.22M | – |
| FY2012 | Jun 30, 2012 | -$1.30M | – |
| FY2011 | Jun 30, 2011 | -$4.29M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $571.51K | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$416.26K | -246.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $107.16K | -59.7% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$194.58K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$363.22K | -330.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $284.83K | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $265.76K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$16.33K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $157.56K | -26.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$153.03K | -125.5% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$58.37K | -612.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$4.62K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $215.67K | +222.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $601.11K | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $11.38K | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$304.41K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $66.88K | -66.3% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$280.42K | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$37.05K | -132.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$171.04K | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $198.23K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$121.45K | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $114.60K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$180.27K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$451.75K | -1939.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$114.58K | -749.6% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$661.41K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$121.84K | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $24.56K | -73.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $17.64K | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$214.81K | -183.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$30.21K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $93.08K | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$80.40K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $256.67K | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$15.42K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$113.71K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$63.01K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$31.35K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$372.91K | – |
See a number that looks wrong?